Chronic non-invasive corticosterone administration abolishes the diurnal pattern of tph2 expression
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Both hypothalamic-pituitary-adrenal (HPA) axis activity and serotonergic systems are commonly dysregulated in stress-related psychiatric disorders. We describe here a non-invasive rat model for hypercortisolism, as observed in major depression, and its effects on physiology, behavior, and the expression of tph2, the gene encoding tryptophan hydroxylase 2, the rate-limiting enzyme for brain serotonin (5-hydroxytryptamine; 5-HT) synthesis. We delivered corticosterone (40 µg/ml, 100 µg/ml or 400 µg/ml) or vehicle to adrenal-intact adult, male rats via the drinking water for three weeks. On days 15, 16, 17 and 18, respectively, the rats’ emotionality was assessed in the open-field (OF), social interaction (SI), elevated plus-maze (EPM), and forced swim tests (FST). On day 21, half of the rats in each group were killed 2 h into the dark phase of a 12/12 h reversed light/dark cycle; the other half were killed 2 h into the light phase. We then measured indices of HPA axis activity, plasma glucose and interleukin-6 (IL-6) availability, and neuronal tph2 expression at each time point. Chronic corticosterone intake was sufficient to cause increased anxiety- and depressive-like behavior in a dose-dependent manner. It also disrupted the diurnal pattern of plasma adrenocorticotropin (ACTH), corticosterone, and glucose concentrations, caused adrenal atrophy, and prevented regular weight gain. No diurnal or treatment-dependent changes were found for plasma levels of IL-6. Remarkably, all doses of corticosterone treatment abolished the diurnal variation of tph2 mRNA expression in the brainstem dorsal raphe nucleus (DR) by elevating the gene’s expression during the animals’ inactive (light) phase. Our data demonstrate that chronic elevation of corticosterone creates a vulnerability to a depression-like syndrome that is associated with increased tph2 expression, similar to that observed in depressed patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822
Procedures for Detecting Outlying Observations in Samples
Grubbs, F. E. (1969) · Technometrics · doi:10.1080/00401706.1969.10490657 · Cited by 4,105 · cited 1×
“Due to outlier identification via the Grubb’s test (Grubbs, 1969), we excluded 6.2% of the data points for ‘immobility’, 7.8% of the data points for the ‘latency until first inner entry’, and 3.1% each of the data points for ‘latency until first center zone entry’, and ‘time in center zone’ from…”
MethodInfluentialHypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress
Tsigos, C., & Chrousos, G. P. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00429-4 · Cited by 2,822 · cited 2×
“…Cassels, 2009), suffer from glucose and insulin resistance (Weber et al., 2000a), and have a higher prevalence for developing obesity, type 2 diabetes, or metabolic syndrome (Tsigos and Chrousos, 2002; Roberge et al., 2007; Anagnostis et al., 2009; Kyrou and Tsigos, 2009; Cagampang et al., 2011).”
BackgroundThe Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
The HPA axis in major depression: classical theories and new developments
Pariante, C. M., & Lightman, S. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.006 · Cited by 2,009
David, D. J., Samuels, B. A., Rainer, Q., Wang, J.-W., Marsteller, D., Mendez, I., Drew, M., Craig, D. A., Guiard, B. P., Guilloux, J.-P., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.04.017 · Cited by 1,267
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147 · cited 2×
“…negative feedback of HPA axis activity (Heuser et al., 1994), possibly due to reduced sensitivity of glucocorticoid receptors either peripherally at the pituitary or centrally at the level of the hypothalamus and limbic structures (Holsboer, 2000; Pariante and Miller, 2001; Pariante, 2009).”
BackgroundSÁNCHEZ, M. M., LADD, C. O., & PLOTSKY, P. M. (2001) · Development and Psychopathology · doi:10.1017/s0954579401003029 · Cited by 1,003
Comorbidity of anxiety and depression in children and adolescents
Brady, E. U., & Kendall, P. C. (1992) · Psychological Bulletin · doi:10.1037/0033-2909.111.2.244 · Cited by 748
Castagné, V., Moser, P., Roux, S., & Porsolt, R. D. (2011) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0810as55 · Cited by 702
PSYCHONEUROENDOCRINOLOGY OF DEPRESSION
Plotsky, P. M., Owens, M. J., & Nemeroff, C. B. (1998) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70006-x · Cited by 672 · cited 2×
“Depressed patients often display hypercortisolism under basal conditions (Plotsky et al., 1998; Barden, 2004; Gillespie and Nemeroff, 2005), a flattened diurnal variation of circulating cortisol (Weber et al., 2000b; Putnam et al., 2008; Van den Bergh and Van Calster, 2009), and an abnormal…”
BackgroundThe combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
Heuser, I., Yassouridis, A., & Holsboer, F. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90017-5 · Cited by 662
Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia
Walker, E., Mittal, V., & Tessner, K. (2008) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.4.022007.141248 · Cited by 615 · cited 2×
“…glucose INTRODUCTION Dysregulation of hypothalamic-pituitary-adrenal (HPA) axis functionality (Daban et al., 2005; Graeff, 2007; Pariante and Lightman, 2008; Walker et al., 2008) and brain serotonergic systems (Mann et al., 1989; Owens and Nemeroff, 1994; Naughton et al., 2000; © 2011 Elsevier Ltd.”
BackgroundImplication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression
Barden, N. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0421 · Cited by 416
Makino, S., Gold, P. W., & Schulkin, J. (1994) · Brain Research · doi:10.1016/0006-8993(94)91862-7 · Cited by 400 · cited 2×
“A potential role for CRF in the central nucleus of the amygdala in glucocorticoid-induced increases in tph2 expression would be supported by findings that glucocorticoids given chronically to adrenal-intact rats increase CRF mRNA expression in the central nucleus of the amygdala (Makino et al., 1994).”
BackgroundLowry, C. A. (2002) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2002.00861.x · Cited by 362 · cited 2×
“It is unclear, however, if HPA axis abnormalities such as hypercortisolemia are a cause or an effect of the observed serotonergic irregularities and behavioral symptoms (Lowry, 2002; Porter et al., 2007; Lanfumey et al., 2008; Heydendael and Jacobson, 2009).”
BackgroundSelf-citationHypercortisolemia and depression
Gillespie, C. F., & Nemeroff, C. B. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000163456.22154.d2 · Cited by 361 · cited 6×
“…from affective disorders as many of them suffer from dysfunctions of circadian rhythms, including HPA axis rhythmicity (Deuschle et al., 1997; Gillespie and Nemeroff, 2005; Graeff, 2007; Wichers et al., 2008a), sleep-wake cycles (Pandi-Perumal et al., 2009; Westrich and Sprouse, 2010), and…”
BackgroundInfluentialDeuschle, M., Schweiger, U., Weber, B., Gotthardt, U., Körner, A., Schmider, J., Standhardt, H., Lammers, C.-H., & Heuser, I. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3689 · Cited by 344
Zill, P., Baghai, T. C., Zwanzger, P., Schüle, C., Eser, D., Rupprecht, R., Möller, H.-J., Bondy, B., & Ackenheil, M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001525 · Cited by 323 · cited 2×
“, 2008) and brain serotonergic systems (Mann et al., 1989; Owens and Nemeroff, 1994; Naughton et al., 2000; Arango et al., 2002; Zill et al., 2004; De Luca et al., 2005; You et al., 2005) is a common feature of many stress-related psychiatric disorders, including major depressive disorder (MDD), bipolar disorder, and…”
BackgroundCryan, J. F., Page, M. E., & Lucki, I. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0093-5 · Cited by 321
An open label trial of C-1073 (mifepristone) for psychotic major depression*
Belanoff, J. K., Rothschild, A. J., Cassidy, F., DeBattista, C., Baulieu, E.-E., Schold, C., & Schatzberg, A. F. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01432-4 · Cited by 320
Young, A. H., Gallagher, P., Watson, S., Del-Estal, D., Owen, B. M., & Nicol Ferrier, I. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300471 · Cited by 318 · cited 1×
“In addition, our data provide further rationale for continued exploration of the use of HPA-axis-targeting medication for patients suffering from affective disorders (O'Dwyer et al., 1995; Belanoff et al., 2002; Pariante et al., 2003; Young et al., 2004).”
BackgroundNeurobiology of early life stress: Clinical studies
Heim, C., & Nemeroff, C. B. (2002) · Seminars in Clinical Neuropsychiatry · doi:10.1053/scnp.2002.33127 · Cited by 307
Anatomic and functional topography of the dorsal raphe nucleus
ABRAMS, J. K., JOHNSON, P. L., HOLLIS, J. H., & LOWRY, C. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1296.005 · Cited by 284 · cited 2×
“(Abrams et al., 2004), and Paxinos & Watson (Paxinos and Watson, 1998), a total of 16 rostro-caudal levels containing 5 functional subdivisions of the DR (dorsal raphe nucleus, caudal part, DRC; dorsal raphe nucleus, dorsal part, DRD; dorsal raphe nucleus, interfascicular part, DRI; dorsal raphe nucleus, ventral part,…”
MethodSelf-citationDroste, S. K., de Groote, L., Atkinson, H. C., Lightman, S. L., Reul, J. M. H. M., & Linthorst, A. C. E. (2008) · Endocrinology · doi:10.1210/en.2008-0103 · Cited by 280
Windle, R. J., Wood, S. A., Shanks, N., Lightman, S. L., & Ingram, C. D. (1998) · Endocrinology · doi:10.1210/en.139.2.443 · Cited by 276 · cited 1×
“We chose this non-invasive drinking-water-mediated paradigm to retain the overall integrity of the diurnal corticosterone rhythmicity present in normal animals (Windle et al., 1998; Droste et al., 2008; Karatsoreos et al., 2010).”
MethodLee, R. S., Tamashiro, K. L. K., Yang, X., Purcell, R. H., Harvey, A., Willour, V. L., Huo, Y., Rongione, M., Wand, G. S., & Potash, J. B. (2010) · Endocrinology · doi:10.1210/en.2010-0225 · Cited by 275
Karatsoreos, I. N., Bhagat, S. M., Bowles, N. P., Weil, Z. M., Pfaff, D. W., & McEwen, B. S. (2010) · Endocrinology · doi:10.1210/en.2009-1436 · Cited by 260 · cited 3×
“For example, opposite effects of chronic corticosterone administration (25 or 100 μg/ml in the drinking water for 4 weeks) on weight gain have been reported in mice (Karatsoreos et al., 2010), and depressed, hypercortisolic human patients display elevated fasting plasma glucose (Roberge et al.”
BackgroundMethodHypothalamic-pituitary-adrenal axis and bipolar disorder
Daban, C., Vieta, E., Mackin, P., & Young, A. H. (2005) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2005.01.005 · Cited by 245 · cited 2×
“…raphe; tph2; tryptophan hydroxylase; serotonin; 5-HT; glucose INTRODUCTION Dysregulation of hypothalamic-pituitary-adrenal (HPA) axis functionality (Daban et al., 2005; Graeff, 2007; Pariante and Lightman, 2008; Walker et al., 2008) and brain serotonergic systems (Mann et al., 1989; Owens and…”
BackgroundMore tryptophan hydroxylase in the brainstem dorsal raphe nucleus in depressed suicides
Boldrini, M., Underwood, M. D., Mann, J. J., & Arango, V. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.083 · Cited by 174 · cited 4×
“…studies of post-mortem tissues from depressed suicide patients, which have consistently found elevated tph2 mRNA and protein expression in the DR (Underwood et al., 1999; Boldrini et al., 2005; Bach-Mizrachi et al., 2006; Bonkale et al., 2006; Bach-Mizrachi et al., 2008; Underwood et al., 2010).”
BackgroundResultInfluentialBach-Mizrachi, H., Underwood, M. D., Tin, A., Ellis, S. P., Mann, J. J., & Arango, V (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002143 · Cited by 153 · cited 2×
“…studies of post-mortem tissues from depressed suicide patients, which have consistently found elevated tph2 mRNA and protein expression in the DR (Underwood et al., 1999; Boldrini et al., 2005; Bach-Mizrachi et al., 2006; Bonkale et al., 2006; Bach-Mizrachi et al., 2008; Underwood et al., 2010).”
BackgroundResultPariante, C. M., Hye, A., Williamson, R., Makoff, A., Lovestone, S., & Kerwin, R. W. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300195 · Cited by 70 · cited 1×
“In addition, our data provide further rationale for continued exploration of the use of HPA-axis-targeting medication for patients suffering from affective disorders (O'Dwyer et al., 1995; Belanoff et al., 2002; Pariante et al., 2003; Young et al., 2004).”
BackgroundCortisol levels in relation to hippocampal sub-regions in subjects with first episode schizophrenia
Gunduz-Bruce, H., Szeszko, P. R., Gueorguieva, R., Ashtari, M., Robinson, D. G., Kane, J. M., & Bilder, R. M. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.03.025 · Cited by 30 · cited 2×
“…of glucocorticoids, as observed in various affective disorders (Plotsky et al., 1998; Barden, 2004; Gillespie and Nemeroff, 2005; Graeff, 2007; Gunduz-Bruce et al., 2007), Cushing’s syndrome (Sonino et al., 1998; Michaud et al., 2009; Pereira et al., 2010), or after prolonged stress exposure…”
Background
Cited by
Russell, G., & Lightman, S. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0228-0 · Cited by 1,032
A users guide to HPA axis research
Spencer, R. L., & Deak, T. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.11.014 · Cited by 405
Sex differences in anxiety and emotional behavior
Donner, N. C., & Lowry, C. A. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1271-7 · Cited by 379
“GC exposure during adulthood [82, 88, 100] are likely to be”
BackgroundSelf-citationEmbracing diversity in the 5-HT neuronal system
Okaty, B. W., Commons, K. G., & Dymecki, S. M. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0151-3 · Cited by 319
Corticotropin-releasing factor-related peptides, serotonergic systems, and emotional behavior
Fox, J. H., & Lowry, C. A. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00169 · Cited by 93
“Repeated administration of UCN 1 into the BLA has also been shown to induce serotonergic changes in the DR, including an increase in tph2 mRNA in specifically the DRVL that was correlated with increases in anxiety-like behavior (Donner et al., 2012a).”
BackgroundSelf-citation
Metadata
- Authors
- Donner, N. C., Montoya, C. D., Lukkes, J. L., & Lowry, C. A.
- Venue
- Psychoneuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 37
- Issue
- 5
- Pages
- 645-661
- ISSN
- 0306-4530 (ISSN-L)
- OpenAlex
- W2123890229
- Cited by
- 89
- References
- 33
- FWCI
- 1.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.